title: Sarcoidosis, neurotoxoplasmosis and golimumab therapy.
authors.affiliation: From the Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India durgapmisra@gmail.com.
authors.forename: D P
authors.initials: DP
authors.lastname: Misra
authors.affiliation: From the Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India.
authors.forename: K G
authors.initials: KG
authors.lastname: Chengappa
authors.affiliation: Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, India.
authors.forename: A
authors.initials: A
authors.lastname: Mahadevan
authors.affiliation: From the Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India.
authors.forename: V K
authors.initials: VK
authors.lastname: Jain
authors.affiliation: From the Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India.
authors.forename: V S
authors.initials: VS
authors.lastname: Negi
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001685:Biological Factors / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D012507:Sarcoidosis / Q000188:drug therapy*; D016781:Toxoplasmosis, Cerebral / Q000000981:diagnostic imaging* / Q000209:etiology / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D001685:Biological Factors; C529000:golimumab